Cat. No.: pGMPC001179
Size: 10 µgConcentration: generally 0.5ug/ul, usually not less than 0.3ug/ulLeading Time: 3-7 working days
Pre-made Human EGFR/ERBB/ERBB1 Non-Viral expression plasmid (overexpression vector) for mouse EGFR overexpression in unique cell transient transfection and stable cell line development.
Select a Price Option:
Academic: Inquiry
Biotech & Pharma & Medical Device & Diagnostics:
Inquiry
CRO & CDMO & CXO & CMC & Manufacturing Company:
Inquiry
Quantity:
Inquiry
Shipping fee: Limited-time free
For payment issues, contact us.
Product Description
Catalog ID
pGMPC001179
Gene Name
EGFR
Accession Number
NM_005228.4
Gene ID
1956
Species
Human
Product Type
Mammalian (Non-Viral Vector) plasmid (overexpression)
Insert Length
3633 bp
Gene Alias
ERBB,ERBB1,HER1,mENA,NISBD2,PIG61
Fluorescent Reporter
ZsGreen
Mammalian Cell Selection
Puromyocin
Fusion Tag
3xflag (C-Terminal)
Promoter
CMV
Resistance
Amplicin
Reference
Data / case study
Click to get more Data /
Case study about the product.
Associated products
Category
Cat No.
Products Name
Biosimilar
GMP-Bios-INN-777
Pre-Made Cetuximab Sarotalocan Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate
Biosimilar
GMP-Bios-ab-102
Pre-Made Cetuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-021
Pre-Made Amivantamab biosimilar, Bispecific mAb, Anti-EGFR;MET Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody
Biosimilar
GMP-Bios-ab-425
Pre-Made Panitumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-324
Pre-Made Losatuxizumab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-227
Pre-Made Futuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-INN-801
Pre-Made Depatuxizumab Mafodotin Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate
Biosimilar
GMP-Bios-ab-197
Pre-Made Etevritamab biosimilar, Bispecific scFv, Anti-EGFR;CD3E Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;T3E/TCRE/IMD18 therapeutic antibody
Biosimilar
GMP-Bios-INN-900
Pre-Made Losatuxizumab Vedotin Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate
Biosimilar
GMP-Bios-ab-377
Pre-Made Nimotuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-371
Pre-Made Necitumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-656
Pre-Made Bafisontamab biosimilar, Whole mAb, Anti-EGFR;MET Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;AUTS9/DFNB97/HGFR/RCCP2/c-Met therapeutic antibody
Biosimilar
GMP-Bios-ab-443
Pre-Made Pimurutamab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-141
Pre-Made Depatuxizumab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-353
Pre-Made Modotuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-440
Pre-Made Petosemtamab biosimilar, Bispecific mAb, Anti-EGFR;LGR5 Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2;FEX/GPR49/GPR67/GRP49/HG38 therapeutic antibody
Biosimilar
GMP-Bios-ab-513
Pre-Made Serclutamab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-INN-884
Pre-Made Laprituximab Emtansine Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate
Biosimilar
GMP-Bios-ab-642
Pre-Made Zatuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-268
Pre-Made Imgatuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-296
Pre-Made Laprituximab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-138
Pre-Made Demupitamab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-INN-988
Pre-Made Serclutamab Talirine Biosimilar, Whole Mab Adc, Anti-Egfr Antibody: Anti-ERBB/ERBB1/ERRP/HER1/NISBD2/PIG61/mENA therapeutic antibody Drug Conjugate
Biosimilar
GMP-Bios-ab-337
Pre-Made Matuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-637
Pre-Made Zalutumumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Biosimilar
GMP-Bios-ab-586
Pre-Made Tomuzotuximab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody
Target Antibody
GM-Tg-g-T59328-Ab
Anti-EGFR/ ERBB/ ERBB1 monoclonal antibody
Target Antigen
GM-Tg-g-T59328-Ag
EGFR VLP (virus-like particle)
Cytokine
cks-Tg-g-GM-T59328
epidermal growth factor receptor (EGFR) protein & antibody
ORF Viral Vector
pGMLP005677
Human EGFR Lentivirus plasmid
ORF Viral Vector
pGMLV000216
Human EGFR Lentivirus plasmid
ORF Viral Vector
pGMLV000217
Human EGFR Lentivirus plasmid
ORF Viral Vector
pGMLV000508
Human EGFR Lentivirus plasmid
ORF Viral Vector
pGMAD000182
Human EGFR Adenovirus plasmid
ORF Viral Vector
pGMPC000460
Human EGFR Mammalian (Non-Viral Vector) plasmid
ORF Viral Vector
pGMPC001179
Human EGFR Mammalian (Non-Viral Vector) plasmid
ORF Viral Vector
vGMLP005677
Human EGFR Lentivirus particle
ORF Viral Vector
vGMLV000216
Human EGFR Lentivirus particle
ORF Viral Vector
vGMLV000217
Human EGFR Lentivirus particle
ORF Viral Vector
vGMLV000508
Human EGFR Lentivirus particle
ORF Viral Vector
vGMAD000182
Human EGFR Adenovirus particle
Target information
Target ID
GM-T59328
Target Name
EGFR
Gene ID
1956 , 13649 , 613027 , 24329 , 100510799 , 404306 , 407217 , 100067755
Gene Symbol and Synonyms
9030024J15Rik,EGFR,ERBB,ErbB-1,ERBB1,Errb1,ERRP,HER1,mENA,NISBD2,PIG61,wa-2,wa2,Wa5
Uniprot Accession
P00533
Uniprot Entry Name
EGFR_HUMAN
Protein Sub-location
Transmembrane Protein
Category
Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target
Disease
Breast Cancer, Non-Small Cell Lung Cancer, gastric cancer, apoptosis, Asphyxia neonatorum, Urinary bladder urothelial carcinoma
Gene Ensembl
ENSG00000146648
Target Classification
Checkpoint-Immuno Oncology, Kinase
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for
QbD Viral vectors Processes development and
manufacturing. In GMVC, our core expertise lies in the
tailored production of viral vectors, including
adeno-associated virus (AAV), lentivirus, and
adenovirus. Our state-of-the-art facilities are equipped
for scalable manufacturing, ensuring high-quality viral
vector production to meet both research and therapeutic
needs. Our expert team specializes in process
development, leveraging innovative technology and
extensive industry knowledge to provide clients with
tailored solutions that exceed expectations. GMVC will
be the ideal partner for scientists and healthcare
professionals seeking reliable and efficient viral
vector production services.